Claire Henchcliffe

5.8k total citations · 2 hit papers
70 papers, 3.3k citations indexed

About

Claire Henchcliffe is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Claire Henchcliffe has authored 70 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Neurology, 23 papers in Molecular Biology and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Claire Henchcliffe's work include Parkinson's Disease Mechanisms and Treatments (41 papers), Neurological disorders and treatments (24 papers) and Pluripotent Stem Cells Research (7 papers). Claire Henchcliffe is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (41 papers), Neurological disorders and treatments (24 papers) and Pluripotent Stem Cells Research (7 papers). Claire Henchcliffe collaborates with scholars based in United States, United Kingdom and Canada. Claire Henchcliffe's co-authors include M. Flint Beal, Robert E. Burke, Malin Parmar, Shane Grealish, Elan D. Louis, Tinmarla F. Oo, Melissa J. Nirenberg, Daniel A. Barone, Harini Sarva and Alexander Shtilbans and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Claire Henchcliffe

68 papers receiving 3.3k citations

Hit Papers

Mitochondrial biology and oxidative stress in Parkinson d... 2008 2026 2014 2020 2008 2025 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
    2008 619 citations Claire Henchcliffe et al. profile →
  2. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
    2025 25 citations Viviane Tabar, Harini Sarva et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Henchcliffe United States 30 1.6k 1.2k 910 503 345 70 3.3k
Julian Großkreutz Germany 38 2.6k 1.6× 1.1k 1.0× 943 1.0× 731 1.5× 467 1.4× 154 4.5k
Masaaki Waragai Japan 30 1.2k 0.8× 1.0k 0.9× 765 0.8× 1.0k 2.1× 466 1.4× 85 3.0k
Dirk Woitalla Germany 32 2.3k 1.5× 944 0.8× 993 1.1× 556 1.1× 503 1.5× 112 3.8k
Naomi P. Visanji Canada 26 1.8k 1.2× 806 0.7× 1.0k 1.1× 527 1.0× 388 1.1× 62 3.0k
Jifeng Guo China 33 1.8k 1.1× 1.6k 1.3× 1.0k 1.1× 725 1.4× 716 2.1× 224 3.9k
Tommaso Schirinzi Italy 29 1.4k 0.9× 708 0.6× 813 0.9× 357 0.7× 328 1.0× 138 2.6k
Sigurlaug Sveinbjörnsdóttir Iceland 18 1.8k 1.1× 691 0.6× 975 1.1× 496 1.0× 536 1.6× 21 3.0k
Tomoyoshi Kondo Japan 34 2.2k 1.4× 954 0.8× 1.4k 1.5× 388 0.8× 461 1.3× 132 3.7k
Sarah Rose United Kingdom 35 2.0k 1.3× 974 0.8× 1.9k 2.1× 731 1.5× 599 1.7× 126 4.4k

Countries citing papers authored by Claire Henchcliffe

Since Specialization
Citations

This map shows the geographic impact of Claire Henchcliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Henchcliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Henchcliffe more than expected).

Fields of papers citing papers by Claire Henchcliffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Henchcliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Henchcliffe. The network helps show where Claire Henchcliffe may publish in the future.

Co-authorship network of co-authors of Claire Henchcliffe

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Henchcliffe. A scholar is included among the top collaborators of Claire Henchcliffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Henchcliffe. Claire Henchcliffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tabar, Viviane, Harini Sarva, Andrés M. Lozano, et al.. (2025). Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease. Nature. 641(8064). 978–983. 25 indexed citations breakdown →
2.
Phielipp, Nicolás & Claire Henchcliffe. (2025). Investigational Gene Therapies for Parkinson's Disease. CNS Drugs. 39(8). 725–737. 1 indexed citations
3.
Fasano, Alfonso, Claire Henchcliffe, Harini Sarva, et al.. (2024). Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-Month Results From a Phase 1 Study. Parkinsonism & Related Disorders. 122. 106129–106129.
4.
Tabar, Viviane, Kenny Kwok Hei Yu, Andrés M. Lozano, et al.. (2024). 510 Dopaminergic Neuronal Cell Therapy for Parkinson’s Disease: Results From a Phase 1 Study of Bemdaneprocel. Neurosurgery. 70(Supplement_1). 156–156. 1 indexed citations
5.
Zein, Sara A., Sneha Pandya, Anastasia Nikolopoulou, et al.. (2021). Population-based input function for TSPO quantification and kinetic modeling with [11C]-DPA-713. EJNMMI Physics. 8(1). 39–39. 6 indexed citations
6.
Barone, Daniel A., Fei Wang, Lisa Ravdin, et al.. (2020). Comorbid neuropsychiatric and autonomic features in REM sleep behavior disorder. Clinical Parkinsonism & Related Disorders. 3. 100044–100044. 5 indexed citations
7.
Berka, Chris, Marija Stevanović Karić, P. David Mozley, et al.. (2020). Neurophysiological Biomarkers of Parkinson’s Disease. Journal of Parkinson s Disease. 10(2). 471–480. 58 indexed citations
8.
Henchcliffe, Claire & Harini Sarva. (2020). Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease. CNS Drugs. 34(6). 559–577. 6 indexed citations
9.
Luo, Lan, Howard Andrews, Roy N. Alcalay, et al.. (2019). Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism & Related Disorders. 65. 178–183. 20 indexed citations
10.
Zhang, Xi, Jian Liang, Cao Xiao, et al.. (2019). Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study. Scientific Reports. 9(1). 797–797. 87 indexed citations
11.
Kang, Yeona, Claire Henchcliffe, Ajay Verma, et al.. (2018). 18F‐FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease. Journal of Neuroimaging. 29(1). 97–103. 26 indexed citations
12.
Kang, Yeona, P. David Mozley, Ajay Verma, et al.. (2018). Noninvasive PK11195‐PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease. Journal of Neuroimaging. 28(5). 496–505. 28 indexed citations
13.
Henchcliffe, Claire & Malin Parmar. (2018). Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies. Journal of Parkinson s Disease. 8(s1). S131–S137. 18 indexed citations
14.
Goldman, Jennifer G., Howard Andrews, Amy W. Amara, et al.. (2017). Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Movement Disorders. 33(2). 282–288. 117 indexed citations
15.
Henchcliffe, Claire, et al.. (2015). Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases. SHILAP Revista de lepidopterología. 11(1). 83–83. 5 indexed citations
16.
Shtilbans, Alexander & Claire Henchcliffe. (2012). Biomarkers in Parkinsonʼs disease. Current Opinion in Neurology. 25(4). 460–465. 51 indexed citations
17.
Cummings, Jeffrey L., et al.. (2011). The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain. 134(11). 3146–3166. 149 indexed citations
18.
Liu, Anli, Michael A. Klufas, Paul J. Christos, et al.. (2010). Clinical predictors of frequent patient telephone calls in Parkinson’s disease. Parkinsonism & Related Disorders. 17(2). 95–99. 15 indexed citations
19.
Louis, Elan D., et al.. (2010). How are we doing with the treatment of essential tremor (ET)?. European Journal of Neurology. 17(6). 882–884. 86 indexed citations
20.
Louis, Elan D., Phyllis L. Faust, Jean‐Paul G. Vonsattel, et al.. (2009). Older onset essential tremor: More rapid progression and more degenerative pathology. Movement Disorders. 24(11). 1606–1612. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julian Großkreutz Breakdown of academic impact, for papers by Masaaki Waragai Breakdown of academic impact, for papers by Dirk Woitalla Breakdown of academic impact, for papers by Naomi P. Visanji Breakdown of academic impact, for papers by Jifeng Guo Breakdown of academic impact, for papers by Tommaso Schirinzi Breakdown of academic impact, for papers by Sigurlaug Sveinbjörnsdóttir Breakdown of academic impact, for papers by Tomoyoshi Kondo Breakdown of academic impact, for papers by Sarah Rose
Rankless by CCL
2026